FR2706767A1 - - Google Patents

Download PDF

Info

Publication number
FR2706767A1
FR2706767A1 FR9307555A FR9307555A FR2706767A1 FR 2706767 A1 FR2706767 A1 FR 2706767A1 FR 9307555 A FR9307555 A FR 9307555A FR 9307555 A FR9307555 A FR 9307555A FR 2706767 A1 FR2706767 A1 FR 2706767A1
Authority
FR
France
Prior art keywords
sep
sec
modafinil
apneas
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR9307555A
Other languages
English (en)
French (fr)
Other versions
FR2706767B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9448411&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2706767(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Priority to FR9307555A priority Critical patent/FR2706767B1/fr
Priority to PT94919708T priority patent/PT705099E/pt
Priority to ES94919708T priority patent/ES2165878T3/es
Priority to DE69428791T priority patent/DE69428791T2/de
Priority to AT94919708T priority patent/ATE207351T1/de
Priority to DK94919708T priority patent/DK0705099T3/da
Priority to JP50249895A priority patent/JP3703831B2/ja
Priority to US08/564,286 priority patent/US5612379A/en
Priority to CA002165824A priority patent/CA2165824C/fr
Priority to KR1019950705833A priority patent/KR100315389B1/ko
Priority to PCT/FR1994/000711 priority patent/WO1995000132A1/fr
Priority to EP94919708A priority patent/EP0705099B1/fr
Priority to AU70760/94A priority patent/AU684087B2/en
Priority to HU9503702A priority patent/HU216731B/hu
Publication of FR2706767A1 publication Critical patent/FR2706767A1/fr
Publication of FR2706767B1 publication Critical patent/FR2706767B1/fr
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Control Of Throttle Valves Provided In The Intake System Or In The Exhaust System (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR9307555A 1993-06-22 1993-06-22 Expired - Fee Related FR2706767B1 (enExample)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR9307555A FR2706767B1 (enExample) 1993-06-22 1993-06-22
CA002165824A CA2165824C (fr) 1993-06-22 1994-06-14 Utilisation du modafinil pour la fabrication d'un medicament ayant un effet sur les apnees du sommeil et les troubles ventilatoires d'origine centrale
PCT/FR1994/000711 WO1995000132A1 (fr) 1993-06-22 1994-06-14 Utilisation du modafinil pour le traitement des apnees du sommeil et troubles ventilatoires d'origine centrale
DE69428791T DE69428791T2 (de) 1993-06-22 1994-06-14 Verwendung vonModafinil zur Behandlung von Atemstillstand im Schlaf und zentral erregten Atembeschwerden
AT94919708T ATE207351T1 (de) 1993-06-22 1994-06-14 Verwendung vonmodafinil zur behandlung von atemstillstand im schlaf und zentral erregten atembeschwerden
DK94919708T DK0705099T3 (da) 1993-06-22 1994-06-14 Anvendelse af modafinil til behandling af søvnapnø og åndedrætslidelser af central oprindelse
JP50249895A JP3703831B2 (ja) 1993-06-22 1994-06-14 中枢起原の睡眠無呼吸症及び呼吸疾患に対する効果を有する医薬の製造のためへのモダフィニルの使用
US08/564,286 US5612379A (en) 1993-06-22 1994-06-14 Modafinil for the treatment of sleep apneas and ventilatory disorders of central origin
PT94919708T PT705099E (pt) 1993-06-22 1994-06-14 Utilizacao do modafinil para o tratamento da apneia do sono e problemas respiratorios de origem central
KR1019950705833A KR100315389B1 (ko) 1993-06-22 1994-06-14 중추유래의수면성무호흡증및호흡곤란증에효과를갖는약제를제조하기위한모다피닐의사용
ES94919708T ES2165878T3 (es) 1993-06-22 1994-06-14 Utilizacion del modafinil para el tratamiento de las apneas del sueño y trastornos de ventilacion de origen central.
EP94919708A EP0705099B1 (fr) 1993-06-22 1994-06-14 Utilisation du modafinil pour le traitement des apnees du sommeil et troubles ventilatoires d'origine centrale
AU70760/94A AU684087B2 (en) 1993-06-22 1994-06-14 Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin
HU9503702A HU216731B (hu) 1993-06-22 1994-06-14 Modafinil alkalmazása alvási apnoe és központi eredetű légzészavarok kezelésére szolgáló gyógyászati készítmény előállítására

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9307555A FR2706767B1 (enExample) 1993-06-22 1993-06-22

Publications (2)

Publication Number Publication Date
FR2706767A1 true FR2706767A1 (enExample) 1994-12-30
FR2706767B1 FR2706767B1 (enExample) 1995-09-08

Family

ID=9448411

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9307555A Expired - Fee Related FR2706767B1 (enExample) 1993-06-22 1993-06-22

Country Status (14)

Country Link
US (1) US5612379A (enExample)
EP (1) EP0705099B1 (enExample)
JP (1) JP3703831B2 (enExample)
KR (1) KR100315389B1 (enExample)
AT (1) ATE207351T1 (enExample)
AU (1) AU684087B2 (enExample)
CA (1) CA2165824C (enExample)
DE (1) DE69428791T2 (enExample)
DK (1) DK0705099T3 (enExample)
ES (1) ES2165878T3 (enExample)
FR (1) FR2706767B1 (enExample)
HU (1) HU216731B (enExample)
PT (1) PT705099E (enExample)
WO (1) WO1995000132A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
JP2002504510A (ja) 1998-02-27 2002-02-12 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ 睡眠時無呼吸に対する処置のための、セロトニン関連活性を有する薬剤
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
US6492396B2 (en) 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
JP4593074B2 (ja) * 2000-10-11 2010-12-08 セフアロン・インコーポレーテツド モダフィニル化合物含有組成物
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
US7297346B2 (en) * 2001-05-25 2007-11-20 Cephalon Inc. Pharmaceutical formulations of modafinil
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040048931A1 (en) 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
IL153098A0 (en) * 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
US7528172B2 (en) * 2003-01-21 2009-05-05 The Cooper Health System, Inc. Compositions and methods for improving recovery after general anesthesia
ES2487415T3 (es) * 2003-03-17 2014-08-20 Neurohealing Pharmaceuticals, Inc. Tratamiento dopaminérgico de alta potencia de deficiencias neurológicas asociadas con lesiones cerebrales
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
EP1586560A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituted arylmethanesulfinyl derivatives
US7423176B2 (en) * 2004-04-13 2008-09-09 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
US7297817B2 (en) * 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
WO2006069030A1 (en) * 2004-12-20 2006-06-29 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
AU2006272874B2 (en) * 2005-07-21 2010-03-11 Neurohealing Pharmaceuticals, Inc. Rapid onset and short term modafinil compositions and methods of use thereof
BRPI0714173A2 (pt) * 2006-07-12 2012-12-25 Elan Pharma Int Ltd composiÇço nanoparticulada estÁvel,mÉtodos para preparar a composiÇço, para prevenir e/ou tratar estados de doenÇas, sintomas, sÍndromes e condiÇÕes do sistema nervoso central, para melhorar ou manter a biodisponibilidade de modafinil, e para tratar distérbio com base neurolàgica, composiÇço farmacÊutica, e forma de dosagem
JP5395663B2 (ja) 2006-08-14 2014-01-22 ニューロヒーリング・ファーマシューティカルズ・インコーポレーテッド モダフィニルによる早漏の治療
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
CN101641090B (zh) * 2006-12-19 2012-12-05 亚勒斯有限公司 莫达非尼在制备治疗多动腿综合征的药物中的应用
AU2011203970A1 (en) * 2010-01-07 2012-07-12 Vivus, Inc. Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent
ES2871381T3 (es) 2013-08-30 2021-10-28 Green Cross Wellbeing Corp Composición para prevenir y tratar la fatiga relacionada con el cáncer, que contiene polvo de ginseng procesado o extracto de ginseng procesado que tiene un componente de ginsenósido mejorado
US9616068B2 (en) 2014-10-27 2017-04-11 Pohela LLC Animal training using cognitive enhancement

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2385693A1 (fr) * 1977-03-31 1978-10-27 Lafon Labor Derives d'acetamide utiles notamment en therapeutique
EP0462004A2 (fr) * 1990-06-14 1991-12-18 Laboratoire L. Lafon Nouvelle utilisation du modafinil
FR2684875A1 (fr) * 1991-12-13 1993-06-18 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2385693A1 (fr) * 1977-03-31 1978-10-27 Lafon Labor Derives d'acetamide utiles notamment en therapeutique
EP0462004A2 (fr) * 1990-06-14 1991-12-18 Laboratoire L. Lafon Nouvelle utilisation du modafinil
FR2684875A1 (fr) * 1991-12-13 1993-06-18 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.

Also Published As

Publication number Publication date
ATE207351T1 (de) 2001-11-15
KR100315389B1 (ko) 2002-02-19
JP3703831B2 (ja) 2005-10-05
WO1995000132A1 (fr) 1995-01-05
CA2165824C (fr) 2005-08-02
KR960703009A (ko) 1996-06-19
PT705099E (pt) 2002-03-28
AU7076094A (en) 1995-01-17
CA2165824A1 (fr) 1995-01-05
DE69428791D1 (de) 2001-11-29
EP0705099A1 (fr) 1996-04-10
EP0705099B1 (fr) 2001-10-24
JPH09500374A (ja) 1997-01-14
HU216731B (hu) 1999-08-30
ES2165878T3 (es) 2002-04-01
AU684087B2 (en) 1997-12-04
DE69428791T2 (de) 2002-07-04
HUT74674A (en) 1997-01-28
US5612379A (en) 1997-03-18
HU9503702D0 (en) 1996-02-28
DK0705099T3 (da) 2002-02-11
FR2706767B1 (enExample) 1995-09-08

Similar Documents

Publication Publication Date Title
EP0705099B1 (fr) Utilisation du modafinil pour le traitement des apnees du sommeil et troubles ventilatoires d'origine centrale
Pekkarinen et al. Sleep apnoea and daytime sleepiness in acromegaly: relationship to endocrinological factors
Whyte et al. Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome
Mellman et al. Electroencephalographic sleep in panic disorder: A focus on sleep-related panic attacks
Gillin et al. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial
Monti et al. Polysomnographic study of the effect of melatonin on sleep in elderly patients with chronic primary insomnia
JP6888026B2 (ja) 概日リズム睡眠障害群を治療する方法
US6387907B1 (en) Use of serotonin agonists to alleviate disordered breathing episodes in a mammal
MXPA05002827A (es) Formulaciones farmaceuticas de modafinil.
CN1303286A (zh) 卡麦角林在治疗多动腿综合征中的应用
IT8249698A1 (it) Preparato farmaceutico contenente un sale di deferossammina per il trattamento di malattia di alzheimer
Plazzi et al. Impact of acute administration of sodium oxybate on nocturnal sleep polysomnography and on multiple sleep latency test in narcolepsy with cataplexy
CN115227825A (zh) Rxr激动剂和甲状腺激素在制备用于治疗自身免疫疾病的药物中的用途
Tassinari et al. The neuropsychiatric syndrome of Δ9-tetrahydrocannabinol and cannabis intoxication in naïve subjects: a clinical and polygraphic study during wakefulness and sleep
JP2501033B2 (ja) Ｄ―フェンフルラミン含有うつ病用医薬組成物
Fukuzako et al. Postural myoclonus associated with long-term administration of neuroleptics in schizophrenic patients
Dement Periodic leg movement, L-dopa, 5-hydroxytryptophan, and L-tryptophan
Knezevic et al. Neuroleptic malignant syndrome
MXPA06006685A (es) Uso de gaboxadol para tratar el insomnio.
WO2022144048A2 (zh) 多酚类化合物在防治脑水肿中的应用
JP6864964B2 (ja) 経口睡眠改善剤
CN114096251A (zh) 用于治疗睡眠问题的莱博雷生
Guilleminault et al. Baclofen trial in six myotonic dystrophy patients
EP2373307A1 (en) Novel use of fibrates
Potolicchio Jr Disorders of excessive sleepiness

Legal Events

Date Code Title Description
ST Notification of lapse